FDA OKs Key Component of Acute Leukemia Regimen

(MedPage Today) -- WASHINGTON--The FDA approved a recombinant form of a key component of a chemotherapy regimen for acute lymphoblastic leukemia (ALL), the most common childhood cancer.
The approval of recombinant asparaginase erwinia chrysanthemi...